Ultimate Access: GCMI’s Medtech Innovation Book of Knowledge
GCMI is now pleased to offer you a deep-dive, behind-the-scenes look at what we do and how we do it in our comprehensive Book of Knowledge.
Dr. Emily Blum, Medical Affairs Liaison for GCMI, Named Emory University Adjunct Assistant Professor
Congratulations to GCMI’s very own: Dr. Emily Blum on her recent advancement within Emory University from Adjunct Clinical Instructor to Adjunct Assistant Professor. The advancement is a testament to Dr. Blum’s commitment to education and clinical research. Emily is instrumental in advancing med tech innovation for GCMI. She works tirelessly to promote GCMI in successfully…
Georgia Bio Names GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award Winner
Georgia Bio, the state’s life science trade association, named GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award recipients. The Innovation Award recognizes the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. In early 2020, U.S. frontline healthcare…
GCMI Interim CEO Sherry Farrugia Named to MUSC Foundation for Research Development Board of Directors
GCMI is proud to announce our Interim CEO, Sherry Farrugia, has been named to the Board of Directors for Medical University of South Carolina Foundation for Research Development (MUSC FRD). “MUSC FRD is pleased to welcome Sherry to the board,” stated Michael Rusnak FRD’s Executive Director of the Board. “Sherry brings over 30 years’…
Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest
There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive. As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…
How do you know you are ready for preclinical work? Insights and recording from our latest webinar.
How can medtech, life science and biopharma innovators know their product is ready for preclinical testing? GCMI Design and Development Director Mike Fisher and Preclinical Program Director Evan Goldberg joined Renovo Biomedical’s Anna Fallon on January 14, 2021 to answer that question.
Testing beyond the bench: how GCMI supported GT Capstone’s “Incisionizers” with early stage validation testing for its novel retraction device.
Georgia Tech recently completed its Fall 2020 (virtual) Capstone Design Expo. From the project’s website, “The Capstone Design Expo showcases Georgia Tech’s graduating seniors as they present their innovative projects designed and built during the Capstone Design Course. Students work in teams to solve either an industry problem, develop innovative tools to assist researchers, or…
News: Georgia Tech Names Raghupathy Sivakumar Inaugural Interim Chief Commercialization Officer
Last month, Georgia Tech named Raghupathy “Siva” Sivakumar inaugural Interim Chief Commercialization Officer. From Georgia Tech Research Horizons: “Sivakumar will bring together commercialization and technology transfer activities from across campus with a goal of moving more intellectual property out into the marketplace to help expand Georgia Tech’s impact on the world. Attaining that goal…
Medtech Innovators and Investors: Are You Wasting Cash In Design & Development?
Watch, listen and learn. Our 2020 AdvanSE session can help you know, and fix, the ways medtech innovators burn cash unnecessarily. Too many promising medtech innovations and early stage companies fail unnecessarily because they run out of funding before achieving milestones required for next-round investments. It is possible to know earlier in the…
ALung Technologies granted Emergency Use Authorization by the FDA for their Hemolung® Respiratory Assist System for the Treatment of COVID-19
A long-time customer of GCMI and T3 Labs, ALung Technologies, has recently announced that they have received FDA Emergency Use Authorization (EUA) for their Hemolung® Respiratory Assist System (RAS), the world’s first fully-integrated respiratory dialysis system. This system removes carbon dioxide directly from the blood, allowing the patient’s lungs to rest and heal while avoiding…